https://orcid.org/0000-0002-6739-0387
References
- Beutler BD, Cohen PR. Molluscum contagiosum of the eyelid: case report in a man receiving methotrexate and literature review of molluscum contagiosum in patients who are immunosuppressed secondary to methotrexate or HIV infection. Dermatol Online J. 2016;22(3):13030/qt8vz669cj. Published 2016 Mar 16.
- Rosner M, Zloto O. Periocular molluscum contagiosum: six different clinical presentations. Acta Ophthalmol. 2018;96(5):e600–e605.
- Blauvelt A, Teixeira HD, Simpson EL, et al. Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial [published correction appears in JAMA dermatol. 2022 feb 1;158(2):219] [published correction appears in JAMA dermatol. 2022 feb 1;158(2):219]. JAMA Dermatol. 2021;157(9):1047–1055.
- Kawano N, Shiratori T, Kawada A. Case of molluscum contagiosum of an aged female in association with the use of upadacitinib. J Dermatol. 2022;49(5):e171–e172.
- Kinoshita M, Ogawa Y, Kawamura T, et al. Case of disseminated molluscum contagiosum caused by ruxolitinib, a janus kinase 1 and 2 inhibitor. J Dermatol. 2016;43(11):1387–1388.
- Wong GN, Lee S, Foley P. A case of widespread molluscum contagiosum caused by baricitinib, a janus kinase inhibitor. Australas J Dermatol. 2019;60(4):e334–e335.